SourceOne, Twin Rivers join hands
SourceOne Global Partners has partnered with Twin Rivers Technologies (TRT) to launch US-produced omega-3s. TRT focuses on omega-3s in the natural triglyceride form. The partnership allows SourceOne to offer a reliable, superior quality omega-3 supply with concentrations up to 90 per cent and EPA/DHA ratios that can be tailored to any specification, the company says. In other news, SourceOne announced the results of a human study comparing the bioavailability of OmegaChoice 90 Concentrated Omega-3 EPA to the same OmegaChoice 90 in the VESIsorb delivery system. The pharmacokinetic pilot study demonstrated the superiority of the formula that utilized the naturally self-assembling VESIsorb delivery system.
Eggshell membrane pact
Stratum Nutrition, a human nutrition division of Novus International, has entered into a 'technology partnership' with ESM Technologies to accelerate the global use of ESM's ingredient NEM (Natural Eggshell Membrane). Novus chose to invest in NEM over other joint-health ingredients due to its small daily-dose size (500mg), a robust yet safe supply chain, and clinically proven results in osteoarthritic patients. In this partnership, Novus will provide sales, marketing and R&D resources to further advance the science behind NEM, as well as the global sales and marketing of the product. Novus launched Stratum in November to focus on a growing portfolio of speciality and functional ingredients.
Krill oil in joint health formulas
Valensa International of Florida has reached an exclusive agreement with Aker BioMarine ASA of Norway to use Aker BioMarine's Superba krill oil in condition-specific dietary-supplement formulas targeting joint health and eye health. Valensa plans on using the highly bio-available omega-3 phospholipids of Aker BioMarine's Superba krill oil, in conjunction with several of its own proprietary ingredients such as Zanthin Natural Astaxanthin, extending its current platform of patented and patent-pending formulations.
Natrol earns cGMP cert from NPA
The Natural Products Association has granted Natrol a Current Good Manufacturing Practices (cGMP) certification as part of its certification programme that also incorporates the Food and Drug Administration's final cGMP rule. Natrol Inc, headquartered in California, is a wholly owned subsidiary of Plethico Pharmaceuticals Ltd.
Danisco website befriends climate
Danisco has created a new Danisco Climate Friendly website aimed at giving manufacturers a fast route to a greener image. As consumers' concern about the climate grows, the first products with carbon labels are appearing on shelves. The website guides food manufacturers to opportunities within five climate-friendly categories, those that reduce energy, water or raw-material consumption, and those that enable material substitution and waste reduction.
Supplier expands echinacea supplies
BI Nutraceuticals has announced that it is increasing its echinacea powder supply, contracting several hundred metric tonnes of echinacea herb and root. Currently, sales of echinacea represent approximately 10 per cent of the US dietary-supplements market, the company said. BI is striving to meet the strong consumer demand "and ensure a seamless production process for our customers."
National Starch to acquire facility
National Starch, a subsidiary of AkzoNobel, has entered into an agreement to acquire Penford's Australian speciality grain wet milling and manufacturing facility based in Lane Cove and certain other intellectual property and assets of Penford's Australian speciality starch business. Terms were not disclosed. The acquisition will expand National Starch's capability to supply food-grade speciality corn starches in the Asia-Pacific region.
ENI, Cargill settle glucosamine suit
Ethical Naturals (ENI) and Cargill Inc have resolved their legal dispute with respect to the production and sale of glucosamine from vegetable sources. ENI owns and markets the GreenGrown brand of vegetable glucosamine and Cargill sells its Regenasure brand. The initial suit, filed in two courts, contended that ENI was infringing Cargill's patents relating to glucosamine manufacture. Both court actions have been withdrawn by Cargill and there was no admission of infringement of Cargill's patents by ENI. Under the terms of the joint settlement and licensing agreement, ENI will continue to market its GreenGrown glucosamine for dietary-supplements use in the US, but will not sell into Canada, the EU or Brazil. ENI will be free to sell GreenGrown for supplement, food and beverage uses in all other parts of the world.